Streetbeat News

MEDS

TRxADE HEALTH, Inc.

https://www.trxadehealth.com

Industry

Medical - Pharmaceuticals

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Open

7.25

Mkt cap

13M

Volume

19K

High

7.70

P/E Ratio

-0.31

52-wk high

44.56

Low

7.06

Div yield

1.25

52-wk low

3.69

In Thursday's after-market session, several health care stocks saw significant movement. Evelo Biosciences, TFF Pharmaceuticals, Anitra, Intensity Therapeutics, Aptevo Therapeutics, and Mesoblast saw gains ranging from 6.58% to 11.7%. On the other hand, BioSig Technologies, Trinity Biotech, Novan, Trxade Health, Cingulate, and Intuitive Surgical saw declines ranging from 4.54% to 7.2%. Intuitive Surgical's Q2 earnings report was released.

Portfolio Pulse from Benzinga Insights

July 20, 2023 | 9:32 pm

TRxADE HEALTH, Inc. (NASDAQ:MEDS) has amended its merger agreement with Superlatus, Inc. The new terms state that Superlatus shareholders will receive an aggregate of 30,821,941 shares of MEDS stock at $7.30 per share. This includes 136,441 shares of MEDS common stock and 306,855 shares of a new class of MEDS non-voting convertible preferred stock. Additionally, TRxADE will issue MEDS Rights to its shareholders, including independent directors, entitling them to one share of MEDS common stock at no cost.

Portfolio Pulse from Happy Mohamed

July 14, 2023 | 8:32 pm

Benzinga's Stock Whisper Index highlights five stocks warranting attention for the week of June 29, 2023. These include Joby Aviation (JOBY), which saw shares soar after receiving a Special Airworthiness Certificate; Minerva Neurosciences (NERV), which saw shares rise after a $20 million investment; Carnival Corporation (CCL), which reported better-than-expected Q2 results; TRxADE Health (MEDS), which saw shares surge year-to-date but sold off after news of an acquisition; and Direxion Small Cap Bull 3X Shares (TNA), an ETF that saw a sharp rise in interest from readers.

Portfolio Pulse from Chris Katje

June 30, 2023 | 2:21 pm

Superlatus, Inc., a U.S.-based food products holding company, has signed a definitive agreement to be acquired by TRxADE HEALTH, Inc. (NASDAQ:MEDS), a pharmaceutical exchange platform provider. Upon closing, Superlatus shareholders will receive an aggregate of 173,463 shares of MEDS stock. MEDS plans to divest its existing operating business and assets shortly after the merger. The combined company will focus on creating a global consolidation platform for the food and healthy snack industry.

Portfolio Pulse from Happy Mohamed

June 30, 2023 | 12:09 pm

During Thursday's intraday session, several healthcare stocks experienced significant movements. Sigilon Therapeutics (SGTX), Immunome (IMNM), Kintara Therapeutics (KTRA), Trxade Health (MEDS), Adamis Pharmaceuticals (ADMP), and Inovio Pharmaceuticals (INO) saw their shares rise, with Sigilon Therapeutics leading the gainers with a 506.6% increase. On the other hand, BioXcel Therapeutics (BTAI), Cormedix (CRMD), Liquidia (LQDA), ATI Physical Therapy (ATIP), Lumos Pharma (LUMO), and Sientra (SIEN) saw their shares decline, with BioXcel Therapeutics leading the losers with a 65.8% decrease.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 5:37 pm

TRxADE Health announced that it will acquire Superlatus, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 6:13 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movement. Minerva Neurosciences (NERV), Immunic (IMUX), Evelo Biosciences (EVLO), Orchestra BioMed Hldgs (OBIO), Theriva Biologics (TOVX), and Immunome (IMNM) saw their shares rise, with Minerva Neurosciences leading the gainers with a 51.1% increase. On the other hand, Trxade Health (MEDS), Cognition Therapeutics (CGTX), Sonnet BioTherapeutics (SONN), Eton Pharmaceuticals (ETON), NeuroBo Pharmaceuticals (NRBO), and Black Diamond Therapeutic (BDTX) experienced a decrease in their stock prices, with Trxade Health leading the losers with a 25.0% drop.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 5:37 pm

12 health care stocks experienced significant price movements during Tuesday's pre-market session, with 6 gainers and 6 losers. Notable gainers include Black Diamond Therapeutic, Biodexa Pharmaceuticals, and CalciMedica, while Adicet Bio, Nemaura Medical, and Trxade Health were among the losers.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 1:12 pm

American Equity Investment Life Holding Company (AEL) shares rose 8.7% in pre-market trading following a report suggesting Brookfield is nearing a deal to acquire the company. Meanwhile, Lordstown Motors Corp. (RIDE) fell 56.2% in pre-market trading after filing for Chapter 11 bankruptcy protection.

Portfolio Pulse from Lisa Levin

June 27, 2023 | 12:19 pm

U.S. stocks traded mixed with the Dow Jones gaining over 50 points, while NASDAQ and S&P 500 fell. Energy shares jumped by 2.2% and communication services shares dipped by 1.4%. TRxADE HEALTH, MoonLake Immunotherapeutics, and Benitec Biopharma saw significant gains, while Avalo Therapeutics, FibroGen, and Biomea Fusion experienced declines.

Portfolio Pulse from Lisa Levin

June 26, 2023 | 7:21 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.